These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36281785)

  • 1. Aminoglycoside-induced lipotoxicity and its reversal in kidney on chip.
    Ioannidis K; Cohen A; Ghosheh M; Ehrlich A; Fischer A; Cohen M; Nahmias Y
    Lab Chip; 2022 Nov; 22(23):4469-4480. PubMed ID: 36281785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium-glucose transporter-2 (SGLT2; SLC5A2) enhances cellular uptake of aminoglycosides.
    Jiang M; Wang Q; Karasawa T; Koo JW; Li H; Steyger PS
    PLoS One; 2014; 9(9):e108941. PubMed ID: 25268124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism and reversal of drug-induced nephrotoxicity on a chip.
    Cohen A; Ioannidis K; Ehrlich A; Regenbaum S; Cohen M; Ayyash M; Tikva SS; Nahmias Y
    Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin, netilmicin, dibekacin, and amikacin nephrotoxicity and its relationship to tubular reabsorption in rabbits.
    Brion N; Barge J; Godefroy I; Dromer F; Dubois C; Contrepois A; Carbon C
    Antimicrob Agents Chemother; 1984 Feb; 25(2):168-72. PubMed ID: 6712201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity.
    Nagai J; Takano M
    Drug Metab Pharmacokinet; 2004 Jun; 19(3):159-70. PubMed ID: 15499183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
    De Broe ME; Giuliano RA; Verpooten GA
    Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoglycoside-induced functional and biochemical defects in the renal cortex.
    Kaloyanides GJ
    Fundam Appl Toxicol; 1984 Dec; 4(6):930-43. PubMed ID: 6519373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of aminoglycoside antibiotics on chicken cystatin binding to renal brush-border membranes.
    Konopska B; Gburek J; Gołąb K; Warwas M
    J Pharm Pharmacol; 2013 Jul; 65(7):988-94. PubMed ID: 23738726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CLIMP-63 is a gentamicin-binding protein that is involved in drug-induced cytotoxicity.
    Karasawa T; Wang Q; David LL; Steyger PS
    Cell Death Dis; 2010 Nov; 1(11):e102. PubMed ID: 21368867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycoside antibiotics alter the electrogenic transport properties of cultured human proximal tubule cells.
    Todd JH; Sens DA; Hazen-Martin DJ; Bylander JE; Smyth BJ; Sens MA
    Toxicol Pathol; 1992; 20(4):608-16. PubMed ID: 1339217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside nephrotoxicity: pathogenesis and prevention.
    Cronin RE
    Clin Nephrol; 1979 May; 11(5):251-6. PubMed ID: 378495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth characteristics of cultured human proximal tubule cells exposed to aminoglycoside antibiotics.
    Sens MA; Hazen-Martin DJ; Blackburn JG; Hennigar GR; Sens DA
    Ann Clin Lab Sci; 1989; 19(4):266-79. PubMed ID: 2757354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased renal accumulation of aminoglycoside reflects defective receptor-mediated endocytosis in cystic fibrosis and Dent's disease.
    Raggi C; Fujiwara K; Leal T; Jouret F; Devuyst O; Terryn S
    Pflugers Arch; 2011 Dec; 462(6):851-60. PubMed ID: 21927812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between the nephrotoxic profile of gentamicin and gentamicin nanoparticles in mice.
    Jamshidzadeh A; Heidari R; Mohammadi-Samani S; Azarpira N; Najbi A; Jahani P; Abdoli N
    J Biochem Mol Toxicol; 2015 Feb; 29(2):57-62. PubMed ID: 25293820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside antibiotics reduce glucose reabsorption in kidney through down-regulation of SGLT1.
    Takamoto K; Kawada M; Usui T; Ishizuka M; Ikeda D
    Biochem Biophys Res Commun; 2003 Sep; 308(4):866-71. PubMed ID: 12927799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megalin deficiency offers protection from renal aminoglycoside accumulation.
    Schmitz C; Hilpert J; Jacobsen C; Boensch C; Christensen EI; Luft FC; Willnow TE
    J Biol Chem; 2002 Jan; 277(1):618-22. PubMed ID: 11700326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
    Whelton A
    Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative nephrotoxicity of dibekacin and gentamicin in rats.
    Elliott WC; Parker RA; Houghton DC; Gilbert DN; Bennett WM
    Res Commun Chem Pathol Pharmacol; 1981 Sep; 33(3):419-32. PubMed ID: 7330450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.